Naftidrofuryl

![Prepn: Szarvasi, Bayssat, FR 1363948 corresp to U.S. Patent 3,334,096 (1964, 1967 both to LIPHA);[4] eidem[5]](/uploads/202501/10/Nafronyl_synthesis.svg5105.png)
Naftidrofuryl (INN, also known as nafronyl or as the oxalate salt naftidrofuryl oxalate or nafronyl oxalate) is a drug used in the management of peripheral and cerebral vascular disorders as a vasodilator. It is also claimed to enhance cellular oxidative capacity, and may also be a 5-HT2 receptor antagonist. It is also licensed for the treatment of intermittent claudication due to peripheral arterial disease.